Application 219395
- Type
- ANDA
- Sponsor
- SPECGX LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | TOFACITINIB | TOFACITINIB CITRATE | TABLET | 5MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219395-001 | TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET / ORAL | AB | 2026-06-03 | |
| A219395-002 | TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2026-06-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219395-001 | AB |
| A219395-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A219395-001 | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET / ORAL | AB | 2026-06-03 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A219395-002 | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2026-06-03 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A219395-001 | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET / ORAL | AB | 2026-06-03 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A219395-002 | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2026-06-03 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A219395-001 | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET / ORAL | AB | 2026-06-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219395-002 | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2026-06-03 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219395-001 | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET / ORAL | AB | 2026-06-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219395-002 | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2026-06-03 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219395-001 | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET / ORAL | AB | 2026-06-03 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219395-002 | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2026-06-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A219395-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A219395-002 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A219395-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A219395-002 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A219395-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219395-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219395-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219395-002 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219395-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219395-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tofacitinib | TOFACITINIB | XLCare Pharmaceuticals Inc | 10403307-e2f9-44d1-bc72-552fdba299d1 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| Tofacitinib | TOFACITINIB | Macleods Pharmaceuticals Limited | 9b654f0d-7705-4880-9e9d-ad3a51e56b56 | 2026-10-22 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| Tofacitinib | TOFACITINIB | Apotex Corp. | 7d4f5cfa-35a8-1458-a609-f6b417946abb | 2026-10-21 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | Stellon Biotech Inc. | 89eb2ffc-02d9-4b46-b480-e9b10af33027 | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB CITRATE |
| TOFACITINIB | TOFACITINIB | Sun Pharmaceutical Industries, Inc. | a764a133-b870-4514-bbee-24d43f8cb7fd | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | CONCORD BIOTECH LIMITED | 6c33e5b4-4843-4a80-a4f8-435bfceddc2a | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB CITRATE |
| Tofacitinib | TOFACITINIB | Saptalis Pharmaceuticals, LLC. | c6c033ff-bce0-4d1c-a182-3b13191686e1 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | Golden State Medical Supply, Inc. | 5dd43533-dadc-2acb-e063-6394a90a413f | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB CITRATE |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 179ffbb2-bedc-40e6-b77b-33d4f7832172 | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | tofacitinib |
| Tofacitinib | TOFACITINIB | Apotex Corp. | dd62a2b8-300b-d92b-7b27-a30eaa68fdd3 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| Tofacitinib | TOFACITINIB | Ajanta Pharma USA Inc. | 024bb9f2-8c26-4d9d-a33b-eb3c0a7c59ed | 2026-10-05 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 21a89264-8047-40ac-8b10-fa6461072509 | 2026-10-05 | Boxed warning, Warnings, Adverse reactions | tofacitinib |
| TOFACITINIB | TOFACITINIB | Bryant Ranch Prepack | 89211a4d-befb-40f1-8792-aa599fdd794c | 2026-10-02 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Micro Labs Limited | ffa6819b-23a4-478b-8fb7-cc90e8142fc5 | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| Tofacitinib | TOFACITINIB | Novadoz Pharmaceuticals LLC | 253635c8-1ea7-41ba-b216-dea5e3305c47 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| TOFACITINIB | TOFACITINIB | Novadoz Pharmaceuticals LLC | 327f6b60-1a5d-49e6-acff-18603d0ee9d0 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| Tofacitinib | TOFACITINIB | Edenbridge Pharmaceuticals LLC. | 576722e5-6639-452d-a5c3-33a064f19481 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| Tofacitinib | TOFACITINIB | Golden State Medical Supply, Inc. | 58f22c41-87d2-e745-e063-6394a90a962e | 2026-08-13 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| Tofacitinib | TOFACITINIB | AvKARE | 5751321a-c904-44ae-e063-6394a90a2654 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | Radha Pharmaceuticals, Inc. | 141ab3eb-982b-4242-89db-6ddce5be0c40 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB CITRATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.